OR WAIT null SECS
December 04, 2013
For its use of innovative technology for the production of seasonal and pandemic influenza vaccines, the Novartis Holly Springs, North Carolina facility was the Overall Winner of the 2013 Facility of the Year Award issued by the International Society for Pharmaceutical Engineering (ISPE).
December 02, 2013
Israel's diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R&D, clinical research, and market growth.
Siegfried Schmitt, principal consultant at PAREXEL, discusses the state of drug manufacturing in India.
The rising cost of drug development and the decreasing proportion of drug-naive population in the US and European markets are driving international pharmaceutical companies to consider emerging markets as a location to conduct their clinical trials. Asia stands out among the emerging markets given its double-digit growth rates.
Ongoing changes create new opportunities for CROs and CMOs.
Pharmaceutical Technology's 2013 Employment Survey reveals some optimism for the industry's future performance, but ongoing concerns about individual job prospects.
Industry mergers, acquisitions and downsizing contribute to uncertainty in job security in the European bio/pharmaceutical market.
American Association of Pharmaceutical Scientists Foundation to assist current and future scientists.
Drug Quality and Security Act gives FDA authority over compounding pharmacies.
November 26, 2013
Thermo Fisher must divest of cell culture media and sera lines, and other businesses, in purchase of Life Technologies.